Corona Vaccination: Pfizer said on Monday that its vaccine for Covid-19 is also effective on children in the age group of five to 11 years and it will try to get approval from the US in this regard. This step of Pfizer is important in the direction of immunization of children.
The vaccine, developed by Pfizer and its German partner BioNTech, is already available for children/adults aged 12 years and older. But now due to the opening of schools in the midst of the outbreak of the pandemic, vaccination of children has become very important because the infection of delta virus in children spreads rapidly and is dangerous for them.
Pfizer tested vaccine doses with very small doses in an age group of children going to elementary/elementary school. This amount is only one third of the normal dose. Dr Bill Gruber, senior vice president of Pfizer, said that after the second dose of its vaccine, the antibodies fighting corona virus infection in children aged five to 11 years were as strong as they are found in adolescents and youth.
He said that the dosage given to children has proved to be safe, they are also seeing the same effects like general fever, pain in the hand, which are seen in adolescents. “I think we’ve come to the right place,” said Gruber, a pediatrician by profession.
Gruber said the company would submit an application to the Food and Drug Administration by the end of this month for emergency use of the vaccine in children aged five to 11 years. The company will also apply to the European and British authorities for the use of the vaccine.